Selected research
Industry Growth & Trends
Global AI in Pharmaceutical Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global AI in Pharmaceutical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for AI in Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for AI in Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI in Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the AI in Pharmaceutical market include Cradle, Prezent, Insilico Medicine, Owkin, Inc, Certara, PathAI, Inc, Aizon, Salesforce, Inc and Aidoc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global AI in Pharmaceutical market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The AI in Pharmaceutical market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI in Pharmaceutical market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI in Pharmaceutical.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global AI in Pharmaceutical market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
AI in Pharmaceutical Market by Company
Cradle
Prezent
Insilico Medicine
Owkin, Inc
Certara
PathAI, Inc
Aizon
Salesforce, Inc
Aidoc
IQVIA
ISOMORPHIC LABS
ConcertAI
Nexocode
BenevolentAI
Recursion
Iktos
XtalPi Inc
AI in Pharmaceutical Segment by Type
Cloud-Based AI Solutions
On-Premises AI Platforms
AI in Pharmaceutical Segment by Application
Drug Discovery and Design
Biomarker Identification
Clinical Trial Optimization
Manufacturing Process Optimization
Others
AI in Pharmaceutical Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI in Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI in Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI in Pharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of AI in Pharmaceutical companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-Based AI Solutions
- On-Premises AI Platforms
Applications
- Drug Discovery and Design
- Biomarker Identification
- Clinical Trial Optimization
- Manufacturing Process Optimization
- Others
Companies covered
- Cradle
- Prezent
- Insilico Medicine
- Owkin, Inc
- Certara
- PathAI, Inc
- Aizon
- Salesforce, Inc
- Aidoc
- IQVIA
- ISOMORPHIC LABS
- ConcertAI
- Nexocode
- BenevolentAI
- Recursion
- Iktos
- XtalPi Inc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global AI in Pharmaceutical Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global AI in Pharmaceutical Market Size by Region (2021-2032)
- 1.4.1 Global AI in Pharmaceutical Market Size by Region (2021-2026)
- 1.4.2 Global AI in Pharmaceutical Market Size by Region (2027-2032)
- 1.5 Key Regions AI in Pharmaceutical Market Size (2021-2032)
- 1.5.1 North America AI in Pharmaceutical Market Size Growth Rate (2021-2032)
- 1.5.2 Europe AI in Pharmaceutical Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific AI in Pharmaceutical Market Size Growth Rate (2021-2032)
- 1.5.4 South America AI in Pharmaceutical Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa AI in Pharmaceutical Market Size Growth Rate (2021-2032)
2 AI in Pharmaceutical Market by Type
- 2.1 Type Introduction
- 2.1.1 Cloud-Based AI Solutions
- 2.1.2 On-Premises AI Platforms
- 2.2 Global AI in Pharmaceutical Market Size by Type
- 2.2.1 Global AI in Pharmaceutical Market Size Overview by Type (2021-2032)
- 2.2.2 Global AI in Pharmaceutical Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global AI in Pharmaceutical Market Size Forecasted by Type (2027-2032)
- 2.3 Global AI in Pharmaceutical Market Size by Regions
- 2.3.1 North America AI in Pharmaceutical Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe AI in Pharmaceutical Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific AI in Pharmaceutical Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America AI in Pharmaceutical Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa AI in Pharmaceutical Market Size Breakdown by Type (2021-2026)
3 AI in Pharmaceutical Market by Application
- 3.1 Type Introduction
- 3.1.1 Drug Discovery and Design
- 3.1.2 Biomarker Identification
- 3.1.3 Clinical Trial Optimization
- 3.1.4 Manufacturing Process Optimization
- 3.1.5 Others
- 3.2 Global AI in Pharmaceutical Market Size by Application
- 3.2.1 Global AI in Pharmaceutical Market Size Overview by Application (2021-2032)
- 3.2.2 Global AI in Pharmaceutical Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global AI in Pharmaceutical Market Size Forecasted by Application (2027-2032)
- 3.3 Global AI in Pharmaceutical Market Size by Regions
- 3.3.1 North America AI in Pharmaceutical Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe AI in Pharmaceutical Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific AI in Pharmaceutical Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America AI in Pharmaceutical Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa AI in Pharmaceutical Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 AI in Pharmaceutical Industry Trends
- 4.2 AI in Pharmaceutical Industry Drivers
- 4.3 AI in Pharmaceutical Industry Opportunities and Challenges
- 4.4 AI in Pharmaceutical Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by AI in Pharmaceutical Revenue (2021-2026)
- 5.2 Global AI in Pharmaceutical Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global AI in Pharmaceutical Key Company Headquarters & Area Served
- 5.4 Global AI in Pharmaceutical Company, Product Type & Application
- 5.5 Global AI in Pharmaceutical Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global AI in Pharmaceutical Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 AI in Pharmaceutical Players Market Share by Revenue in 2025
- 5.6.3 2025 AI in Pharmaceutical Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Cradle
- 6.1.1 Cradle Company Information
- 6.1.2 Cradle Business Overview
- 6.1.3 Cradle AI in Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Cradle AI in Pharmaceutical Product Portfolio
- 6.1.5 Cradle Recent Developments
- 6.2 Prezent
- 6.2.1 Prezent Company Information
- 6.2.2 Prezent Business Overview
- 6.2.3 Prezent AI in Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Prezent AI in Pharmaceutical Product Portfolio
- 6.2.5 Prezent Recent Developments
- 6.3 Insilico Medicine
- 6.3.1 Insilico Medicine Company Information
- 6.3.2 Insilico Medicine Business Overview
- 6.3.3 Insilico Medicine AI in Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Insilico Medicine AI in Pharmaceutical Product Portfolio
- 6.3.5 Insilico Medicine Recent Developments
- 6.4 Owkin, Inc
- 6.4.1 Owkin, Inc Company Information
- 6.4.2 Owkin, Inc Business Overview
- 6.4.3 Owkin, Inc AI in Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Owkin, Inc AI in Pharmaceutical Product Portfolio
- 6.4.5 Owkin, Inc Recent Developments
- 6.5 Certara
- 6.5.1 Certara Company Information
- 6.5.2 Certara Business Overview
- 6.5.3 Certara AI in Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Certara AI in Pharmaceutical Product Portfolio
- 6.5.5 Certara Recent Developments
- 6.6 PathAI, Inc
- 6.6.1 PathAI, Inc Company Information
- 6.6.2 PathAI, Inc Business Overview
- 6.6.3 PathAI, Inc AI in Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 PathAI, Inc AI in Pharmaceutical Product Portfolio
- 6.6.5 PathAI, Inc Recent Developments
- 6.7 Aizon
- 6.7.1 Aizon Company Information
- 6.7.2 Aizon Business Overview
- 6.7.3 Aizon AI in Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Aizon AI in Pharmaceutical Product Portfolio
- 6.7.5 Aizon Recent Developments
- 6.8 Salesforce, Inc
- 6.8.1 Salesforce, Inc Company Information
- 6.8.2 Salesforce, Inc Business Overview
- 6.8.3 Salesforce, Inc AI in Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Salesforce, Inc AI in Pharmaceutical Product Portfolio
- 6.8.5 Salesforce, Inc Recent Developments
- 6.9 Aidoc
- 6.9.1 Aidoc Company Information
- 6.9.2 Aidoc Business Overview
- 6.9.3 Aidoc AI in Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Aidoc AI in Pharmaceutical Product Portfolio
- 6.9.5 Aidoc Recent Developments
- 6.10 IQVIA
- 6.10.1 IQVIA Company Information
- 6.10.2 IQVIA Business Overview
- 6.10.3 IQVIA AI in Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 IQVIA AI in Pharmaceutical Product Portfolio
- 6.10.5 IQVIA Recent Developments
- 6.11 ISOMORPHIC LABS
- 6.11.1 ISOMORPHIC LABS Company Information
- 6.11.2 ISOMORPHIC LABS Business Overview
- 6.11.3 ISOMORPHIC LABS AI in Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 ISOMORPHIC LABS AI in Pharmaceutical Product Portfolio
- 6.11.5 ISOMORPHIC LABS Recent Developments
- 6.12 ConcertAI
- 6.12.1 ConcertAI Company Information
- 6.12.2 ConcertAI Business Overview
- 6.12.3 ConcertAI AI in Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 ConcertAI AI in Pharmaceutical Product Portfolio
- 6.12.5 ConcertAI Recent Developments
- 6.13 Nexocode
- 6.13.1 Nexocode Company Information
- 6.13.2 Nexocode Business Overview
- 6.13.3 Nexocode AI in Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Nexocode AI in Pharmaceutical Product Portfolio
- 6.13.5 Nexocode Recent Developments
- 6.14 BenevolentAI
- 6.14.1 BenevolentAI Company Information
- 6.14.2 BenevolentAI Business Overview
- 6.14.3 BenevolentAI AI in Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 BenevolentAI AI in Pharmaceutical Product Portfolio
- 6.14.5 BenevolentAI Recent Developments
- 6.15 Recursion
- 6.15.1 Recursion Company Information
- 6.15.2 Recursion Business Overview
- 6.15.3 Recursion AI in Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Recursion AI in Pharmaceutical Product Portfolio
- 6.15.5 Recursion Recent Developments
- 6.16 Iktos
- 6.16.1 Iktos Company Information
- 6.16.2 Iktos Business Overview
- 6.16.3 Iktos AI in Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Iktos AI in Pharmaceutical Product Portfolio
- 6.16.5 Iktos Recent Developments
- 6.17 XtalPi Inc
- 6.17.1 XtalPi Inc Company Information
- 6.17.2 XtalPi Inc Business Overview
- 6.17.3 XtalPi Inc AI in Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 XtalPi Inc AI in Pharmaceutical Product Portfolio
- 6.17.5 XtalPi Inc Recent Developments
7 North America
- 7.1 North America AI in Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America AI in Pharmaceutical Market Size by Country (2021-2026)
- 7.3 North America AI in Pharmaceutical Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe AI in Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe AI in Pharmaceutical Market Size by Country (2021-2026)
- 8.3 Europe AI in Pharmaceutical Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific AI in Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific AI in Pharmaceutical Market Size by Country (2021-2026)
- 9.3 Asia-Pacific AI in Pharmaceutical Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America AI in Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America AI in Pharmaceutical Market Size by Country (2021-2026)
- 10.3 South America AI in Pharmaceutical Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa AI in Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa AI in Pharmaceutical Market Size by Country (2021-2026)
- 11.3 Middle East & Africa AI in Pharmaceutical Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst